InvestorsHub Logo
Followers 6
Posts 1087
Boards Moderated 0
Alias Born 07/18/2006

Re: biotech_researcher post# 6956

Friday, 04/20/2018 9:46:59 AM

Friday, April 20, 2018 9:46:59 AM

Post# of 17420
"....they claim 278 million individuals have SLE."

Obvious misprint- they meant to say 278 thousand. 60% of that number gives an approximation of the number of LN sufferers- about 167 thousand.

If you take that number and figure 20% will take Voclosporin at an annual cost of 35K you get a number over $1B.

Seems realistic to me.

Fooling around with the numbers, if VCS works for SLE, all 278 thousand could take the drug for $7000 annually (doesn't include the cost of the drug to manufacture, market, distribute, etc.) and get to a $2B annual sales number.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News